A team of researchers has revived human retinas after death, demonstrating that donor eye tissue can detect light for up to 10 hours following cardiac death when properly perfused with oxygenated blood. The finding opens new pathways for whole-eye transplantation that could restore vision to the blind.
Scientists perfused donor human retinas with a specialized nutrient solution containing oxygen and blood components, mimicking conditions inside a living eye. Under these conditions, the photoreceptor cells in the retina continued responding to light stimuli, even after the donor had been deceased for several hours. Researchers measured this response using electroretinography, which detects electrical signals generated when light hits the eye.
The work represents a major advance in transplantation biology. Previous research showed that retinal cells could survive in culture after death, but this study demonstrates that intact retinal tissue maintains its fundamental light-sensing function in a more lifelike environment. This functional recovery extends the window for transplanting eye tissue and suggests that vision-restoring transplants may become feasible.
The retina's ability to respond to light after death suggests that other neural tissues in the eye may similarly preserve function under proper conditions. Researchers believe this approach could eventually allow surgeons to test donor eyes before transplantation, ensuring tissue quality and improving transplant success rates.
The study faces practical limitations. Perfusing retinas requires specialized equipment and expertise that few centers currently possess. Scaling the technology for routine clinical use will require standardized protocols and training. Additionally, restoring light detection in the retina is only one component of restoring vision. The optic nerve and visual cortex must also function properly for patients to see.
Despite these challenges, the research demonstrates that death does not immediately destroy the eye's capacity to detect light. This finding could accelerate development of whole-eye transplantation techniques and improve outcomes for patients awaiting vision restoration